Enabling you to identify and mitigate the intrinsic risk in your operations, supply chains and business processes.
Evaluating how your products and services meet and exceed quality, safety, sustainability and performance standards.
Validating the specifications, value and safety of your raw materials, products and assets.
Intertek, a leading Total Quality Assurance provider to industries worldwide, and the China Chamber of Commerce for Import & Export of Medicines & Health Products (CCCMHPIE) have signed a Joint Venture (JV) agreement to establish a pharmaceutical and healthcare analytical laboratory in China.
The pharmaceutical and healthcare product industry is an emerging sector in China and promises significant potential for development both domestically and internationally. The JV will be majority owned by Intertek and will help Chinese health product manufacturers to achieve quality and safety assurance across their products and supply chains.
Intertek was the first international third party quality and safety service provider to enter China in 1989 and has over 100 labs and offices in more than 40 cities with over 9,600 employees across China. Through its global network and in-depth knowledge, Intertek can provide the expertise to support product development and industry growth for the pharmaceutical, biopharmaceutical and medical device industry. In addition, its Assurance solutions allow clients to identify and mitigate risks associated with products, processes, operational and quality management systems, assets and supply chains to achieve Total Quality Assurance.
CCCMHPIE is a leading national trade association in China and is playing an active role in formulating and implementing government policies and promoting international trade and investment in the medicine and healthcare industry.
“Intertek is excited to work with CCCMHPIE to gain further access to the developing Chinese pharmaceutical and healthcare product market”, said Fred Bai, Chief Executive Officer of Intertek China. “With Intertek’s world-class expertise and industry specific knowledge, we look forward to supporting CCCMHPIE’s initiatives in strengthening and optimizing the quality assurance programs of Chinese manufacturers, providing them with a competitive advantage both domestically and abroad.”
A representative of CCCMHPIE stated, “In recent years, China’s pharmaceutical and healthcare companies are exploring international markets with increased demand for product registration and quality systems certification. To meet their diverse needs and facilitate international trade and growth, CCCMHPIE, together with Intertek, will deliver a one-stop service ‘Intertek Life Bridge’, with tailor-made solutions offering comprehensive product quality and safety testing. We look forward to working closely with Intertek and exploring our mutual resources to support the industry in its international and domestic expansion.”
Intertek is a leading Total Quality Assurance provider to industries worldwide. Our network of more than 1,000 laboratories and offices and over 40,000 people in more than 100 countries, delivers innovative and bespoke Assurance, Testing, Inspection and Certification solutions for our customers’ operations and supply chains.
Bringing quality and safety to life
Founded in May 1989 and affiliated to the Ministry of Commerce of China, CCCMHPIE has a diverse membership of more than 2,400 members including the majority of major R&D facilities, manufacturers and trading companies in China. As the leading and most authoritative investment and trade promotion organization in the Chinese healthcare sector, CCCMHPIE provides one-stop services to the healthcare industry in the areas of policy & industry coordination, product & market analysis, registration & certification and consultation, serving as the bridge between authorities and enterprises, both at home and abroad.
For further information, please contact:
China Marketing & PR Manager
+86 21 6127 8462